MANGALAM DRUGS Share price, NSE/BSE Forecast News and Quotes| Equitymaster
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MANGALAM DRUGS Share Price   (MANGD)

Here is the latest stock price and chart of MANGALAM DRUGS. For a sector overview, read our pharmaceuticals sector report.

REFRESH
Live BSE Quotes Jul 23, 2018 03:21:00 PM
Price (Rs)71.45 Open (Rs) 75.00 High (Rs) 75.00 Low (Rs) 71.45
% Change-4.99 Volume 6,798 Value (Rs) 485,717 52-Week H/L 225.90 / 75.20
Live NSE Quotes Jul 23, 2018 3:23:59 PM
Price (Rs)71.55 Open (Rs) 71.55 High (Rs) 71.55 Low (Rs) 71.55
% Change-4.98 Volume 16,794 Value (Rs) 1,201,611 52-Week H/L 225.70 / 75.30
  BSE Sensex | CNX Nifty


MANGALAM DRUGS Share Price Today:

MANGALAM DRUGS share price has hit a 52-week low. It's share price has tanked 5.0% to Rs 71.5 on the BSE. On the NSE, the MANGALAM DRUGS share price has tanked 5.0% to Rs 71.6. The total volume of shares traded is 0.0 m.

Overall, the broader S&P BSE HEALTHCARE Index is trading up by 0.8%. And the benchmark S&P BSE SENSEX is at 36,714.0 (up 0.6%).

Over the last 30 days, the MANGALAM DRUGS share price is down 30.5%. And over the last one year, MANGALAM DRUGS share price is down 57.4%.





Today's Market

Indian Share Markets Trade Marginally Up; FMCG Sector Rallies(12:30 pm)

Stock markets in India are trading higher presently. Gains are largely seen in FMCG stocks and consumer durables' stocks.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK MANGALAM DRUGS

  • Track your investment in MANGALAM DRUGS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MARKET STATS